"septic"; Stage 3 Kidney Disease; "losing her hair"; This spontaneous case was reported by a consumer and describes the occurrence of SEPSIS ("septic") and CHRONIC KIDNEY DISEASE (Stage 3 Kidney Disease) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Renal disease (Recent change in status: Worsening) since 2016 and Sepsis.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On an unknown date, the patient experienced SEPSIS ("septic") (seriousness criteria hospitalization and medically significant), CHRONIC KIDNEY DISEASE (Stage 3 Kidney Disease) (seriousness criteria hospitalization and medically significant) and ALOPECIA ("losing her hair"). The patient was hospitalized on sometime in March 2022 due to CHRONIC KIDNEY DISEASE and SEPSIS. At the time of the report, SEPSIS ("septic") and CHRONIC KIDNEY DISEASE (Stage 3 Kidney Disease) had not resolved and ALOPECIA ("losing her hair") outcome was unknown.            No concomitant medications were reported. Patient was unable to report the date the hair loss started, but mentioned it started sometime after getting the Moderna COVID-19 vaccine. The patient was in the hospital.  Patient reported was admitted to the hospital six days ago. Currently hospitalized due to Stage 3 Kidney Disease and was currently "septic" - mentioning "it is really bad this time". Patient reported was diagnosed with kidney disease in 2016. Patient was unable to provide the exact dates of the Moderna COVID-19 vaccinations. Patient did report patient received the first dose in March 2021 and the second dose in April 2021. It is unknown when patient received the booster dose. Moderna lot numbers were not available at the time of the call. Patient had to end the call early since was in the hospital and a Health Care Provider came to visit and speak with patient. Additional patient demographics were not provided by the patient since the call was ended early by the patient.  No treatment details were reported.  Company comment: This is a spontaneous case concerning a female patient of unknown age, with a history of nephropathy since 2016, who experienced the serious (due to hospitalization and medically significant) unexpected, events of Chronic kidney disease (reported as kidney disease stage 3 worsened) and sepsis. The events occurred on an unknown date after the mRNA-1273 vaccination. The mentioned medical history remains as a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-512240 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a female patient of unknown age, with a history of nephropathy since 2016, who experienced the serious (due to hospitalization and medically significant) unexpected, events of Chronic kidney disease (reported as kidney disease stage 3 worsened) and sepsis. The events occurred on an unknown date after the mRNA-1273 vaccination. The mentioned medical history remains as a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.